Arya Biragyn

11.9k total citations · 5 hit papers
96 papers, 8.8k citations indexed

About

Arya Biragyn is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Arya Biragyn has authored 96 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Immunology, 32 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Arya Biragyn's work include Immunotherapy and Immune Responses (36 papers), T-cell and B-cell Immunology (18 papers) and Immune Cell Function and Interaction (17 papers). Arya Biragyn is often cited by papers focused on Immunotherapy and Immune Responses (36 papers), T-cell and B-cell Immunology (18 papers) and Immune Cell Function and Interaction (17 papers). Arya Biragyn collaborates with scholars based in United States, Italy and Israel. Arya Biragyn's co-authors include Joost J. Oppenheim, Larry W. Kwak, Monica Bodogai, De Yang, Emeline Ragonnaud, Purevdorj B. Olkhanud, Ronald E. Gress, Pier Adelchi Ruffini, Katarzyna Wejksza and Elena Klyushnenkova and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Arya Biragyn

93 papers receiving 8.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease

2015 1.6k citations Monica Bodogai, Arya Biragyn et al. profile →
Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2

2002 711 citations Arya Biragyn, Pier Adelchi Ruffini et al. profile →
Mammalian defensins in immunity: more than just microbicidal

2002 568 citations De Yang, Arya Biragyn et al. profile →
Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells

2011 519 citations Purevdorj B. Olkhanud, Bazarragchaa Damdinsuren et al. Cancer Research profile →
Gut microbiota as the key controllers of “healthy” aging of elderly people

2021 261 citations Emeline Ragonnaud, Arya Biragyn profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arya Biragyn United States	40	3.9k	3.4k	1.8k	1.5k	1.4k	96	8.8k
O. M. Zack Howard United States	58	5.4k 1.4×	3.4k 1.0×	684 0.4×	2.4k 1.5×	1.4k 1.0×	131	10.7k
Ji Ming Wang United States	59	4.3k 1.1×	4.9k 1.4×	1.1k 0.6×	2.4k 1.6×	817 0.6×	148	10.0k
Cláes Dahlgren Sweden	51	5.6k 1.4×	5.4k 1.6×	1.3k 0.7×	754 0.5×	1.0k 0.8×	279	10.2k
Tadashi Kasahara Japan	56	4.1k 1.1×	3.8k 1.1×	1.3k 0.7×	1.6k 1.1×	223 0.2×	248	10.8k
Michel Chignard France	56	3.9k 1.0×	2.4k 0.7×	1.2k 0.7×	629 0.4×	486 0.4×	187	10.3k
Ruey‐Bing Yang Taiwan	36	3.3k 0.9×	3.2k 0.9×	467 0.3×	647 0.4×	614 0.4×	93	8.5k
Lennart Lindbom Sweden	45	3.5k 0.9×	2.0k 0.6×	812 0.4×	469 0.3×	948 0.7×	125	7.9k
Terry K. Means United States	45	6.9k 1.8×	2.2k 0.6×	1.5k 0.8×	1.1k 0.7×	550 0.4×	69	11.1k
Yoshinori Nagai Japan	40	5.3k 1.4×	2.1k 0.6×	920 0.5×	475 0.3×	733 0.5×	133	8.8k
Daniela N. Männel Germany	44	4.8k 1.2×	2.6k 0.8×	931 0.5×	1.5k 1.0×	215 0.2×	145	9.1k

Countries citing papers authored by Arya Biragyn

Since Specialization

Citations

This map shows the geographic impact of Arya Biragyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arya Biragyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arya Biragyn more than expected).

Fields of papers citing papers by Arya Biragyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arya Biragyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arya Biragyn. The network helps show where Arya Biragyn may publish in the future.

Co-authorship network of co-authors of Arya Biragyn

This figure shows the co-authorship network connecting the top 25 collaborators of Arya Biragyn. A scholar is included among the top collaborators of Arya Biragyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arya Biragyn. Arya Biragyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shoval, Irit, Hagit Hauschner, Ravit Madar, et al.. (2025). Dural ectopic lymphatic structures accumulate during aging and exhibit dysregulation in neurodegenerative diseases. Proceedings of the National Academy of Sciences. 122(33). e2425081122–e2425081122.

Wang, Xin, Monica Bodogai, Ross A. McDevitt, et al.. (2024). CD8+ T cells exacerbate AD-like symptoms in mouse model of amyloidosis. Brain Behavior and Immunity. 122. 444–455. 9 indexed citations

Bodogai, Monica, Melissa Carpenter, Priya Krishna, et al.. (2022). Replenishment of myeloid-derived suppressor cells (MDSCs) overrides CR-mediated protection against tumor growth in a murine model of triple-negative breast cancer. GeroScience. 44(5). 2471–2490. 5 indexed citations

Bodogai, Monica, Jonathan Kato, Melissa Carpenter, et al.. (2021). Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition. Nature Communications. 12(1). 6201–6201. 79 indexed citations

Ragonnaud, Emeline, Kanako Moritoh, Monica Bodogai, et al.. (2019). Tumor-Derived Thymic Stromal Lymphopoietin Expands Bone Marrow B-cell Precursors in Circulation to Support Metastasis. Cancer Research. 79(22). 5826–5838. 22 indexed citations

Biragyn, Arya, et al.. (2018). 腸疾患:加齢と炎症における癌リスク増加の潜在的関連【JST・京大機械翻訳】. The Lancet Oncology. 19(6). 295–304. 1 indexed citations

Bodogai, Monica, Kanako Moritoh, Catalina Lee-Chang, et al.. (2015). Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells. Cancer Research. 75(17). 3456–3465. 122 indexed citations

Kapogiannis, Dimitrios, Adam L. Boxer, Erin L. Abner, et al.. (2015). Neural origin plasma exosomes provide novel biomarkers for brain insulin resistance in Alzheimer's disease (I11-5B). Neurology. 84(14_supplement). 1 indexed citations

Bodogai, Monica, Catalina Lee-Chang, Katarzyna Wejksza, et al.. (2013). Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L. Cancer Research. 73(7). 2127–2138. 112 indexed citations

10.

Bodogai, Monica, et al.. (2012). Failure of Rituximab in solid tumors is due to its inability to eliminate tumor evoked B regulatory cells (165.15). The Journal of Immunology. 188(1_Supplement). 165.15–165.15. 1 indexed citations

11.

Olkhanud, Purevdorj B., Bazarragchaa Damdinsuren, Monica Bodogai, et al.. (2011). Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells. Cancer Research. 71(10). 3505–3515. 519 indexed citations breakdown →

12.

Olkhanud, Purevdorj B., Dolgor Baatar, Monica Bodogai, et al.. (2009). Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells. Cancer Research. 69(14). 5996–6004. 240 indexed citations

13.

Prabakaran, Ponraj, Zhongyu Zhu, Xiaodong Xiao, et al.. (2009). Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. Expert Opinion on Biological Therapy. 9(3). 355–368. 38 indexed citations

14.

Baatar, Dolgor, Purevdorj B. Olkhanud, Valerie Wells, et al.. (2009). Tregs utilize β-galactoside-binding protein to transiently inhibit PI3K/p21ras activity of human CD8+ T cells to block their TCR-mediated ERK activity and proliferation. Brain Behavior and Immunity. 23(7). 1028–1037. 15 indexed citations

15.

Baatar, Dolgor, et al.. (2007). CCR4-Expressing T Cell Tumors Can Be Specifically Controlled via Delivery of Toxins to Chemokine Receptors. The Journal of Immunology. 179(3). 1996–2004. 30 indexed citations

16.

Baatar, Dolgor, et al.. (2007). Human Peripheral Blood T Regulatory Cells (Tregs), Functionally Primed CCR4+ Tregs and Unprimed CCR4− Tregs, Regulate Effector T Cells Using FasL. The Journal of Immunology. 178(8). 4891–4900. 79 indexed citations

17.

Biragyn, Arya, De Yang, Pier Adelchi Ruffini, et al.. (2001). Mediators of Innate Immunity That Target Immature, But Not Mature, Dendritic Cells Induce Antitumor Immunity When Genetically Fused with Nonimmunogenic Tumor Antigens. The Journal of Immunology. 167(11). 6644–6653. 235 indexed citations

18.

Biragyn, Arya, et al.. (1999). Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nature Biotechnology. 17(3). 253–258. 240 indexed citations

19.

Kuprash, Dmitry V., Oleg Osipovich, Dmitry Pokholok, et al.. (1996). Functional analysis of the lymphotoxin-β promoter. Sequence requirements for PMA activation. The Journal of Immunology. 156(7). 2465–2472. 32 indexed citations

20.

Lloyd, Andrew R., Arya Biragyn, James A. Johnston, et al.. (1995). Granulocyte-Colony Stimulating Factor and Lipopolysaccharide Regulate the Expression of Interleukin 8 Receptors on Polymorphonuclear Leukocytes. Journal of Biological Chemistry. 270(47). 28188–28192. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact